UnitedHealth: 3 Key Takeaways for Long-Term Investors
Key Points
AI chart summarization expanded to 40% of clinicians, cutting review time by 33%.
UnitedHealth will reduce total prior authorizations by 30% by year end.
Third quarter revenue reached $113 billion with adjusted earnings per share of $4.69.
- Motley Fool Issues Rare "Total Conviction" Buy Alert ›
On its third quarter of 2026 earnings call, held on Oct. 13, UnitedHealth (NYSE:UNH) reiterated its target of 13% to 16% long-term growth as operational reforms take hold. The health services and insurance provider is expanding artificial intelligence tools and streamlining clinical processes to improve operational efficiency.
These operational shifts directly impact cost control, client retention, and multiyear profitability. Three takeaways stand out for long-term investors.
1. Artificial Intelligence Streamlines Workflows and Reduces Costs
Integrating artificial intelligence into daily operations reduces administrative delays and frees up medical staff. Lowering administrative overhead improves service speed, so the business doesn't waste operational resources.
Across the businesses, AI-enabled capabilities are beginning to help clinicians spend more time with patients, improve service speed and experience, streamline administration, and reduce friction for both consumers and clinicians.
-- Steve Hemsley, Chairman and Chief Executive Officer
2. Enterprise Reforms Cut Prior Authorization Administrative Burdens
Prior authorization, the requirement that doctors get insurer approval before delivering certain treatments, creates heavy operational friction. Reducing these approvals by 30% simplifies care for patients and cuts administrative expenses.
Collectively, these initiatives will reduce total prior authorizations by 30%, including a reduction of two-thirds in prior authorizations for people under age 18.
-- Steve Hemsley, Chairman and Chief Executive Officer
3. High Retention in Commercial Accounts Protects Revenue Stability
Persistency, the percentage of commercial health insurance clients who renew their plans, remains strong among large national accounts. Retaining employer customers secures predictable premium revenue while the company manages medical cost pressures.
We're coming off of two really strong years in national account sales, and we're pleased to see that our persistency and our group retention looks very strong going into 2027.
-- Brandon Cuevas, CEO of our commercial business
Looking Ahead
Operational momentum across health services and insurance businesses supports long-term target earnings growth. Disciplined pricing, expanded value-based care (where providers are paid for patient outcomes rather than service volume), and automated workflows bolster margins while management tracks medical costs.
Our third quarter performance reflects actions taken throughout 2026, driving meaningful progress and reinforcing our confidence to sustainably grow in 2027 and beyond within our 13%-16% long-term target growth range.
-- Steve Hemsley, Chairman and Chief Executive Officer
Enterprise modernization efforts continue to deliver tangible operating gains.
The progress we've made in 2026 gives us confidence. Our businesses are improving. Our modernization efforts are gaining traction. Our investments in AI and in integrated value-based care are creating tangible benefits today while positioning us for the future.
-- Steve Hemsley, Chairman and Chief Executive Officer
Should you buy stock in UnitedHealth Group right now?
Before you buy stock in UnitedHealth Group, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and UnitedHealth Group wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $380,363!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,315,732!*
Now, it’s worth noting Stock Advisor’s total average return is 919% — a market-crushing outperformance compared to 211% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of October 17, 2026.
The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy.
Recommended Articles
